PharmaPoint: Meningococcal Vaccines - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Meningococcal Vaccines - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Meningococcal Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Meningococcal Vaccines market. The report provides insight into the competitive Meningococcal Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Meningococcal Vaccines

- Competitor assessment

- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

- Strategic assessment of the Meningococcal Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving the Meningococcal Vaccines Market

- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

- What’s the next big thing in the global Meningococcal Vaccines market landscape? Identify, understand and capitalize

Table Of Contents

Table of Contents

1 Table of Contents 7
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
2.3 Upcoming Related Reports 11
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers - Global Issues 16
4 Current and Future Players 20
4.1 Overview 20
4.2 Trends in Corporate Strategy 24
4.3 Company Profiles 26
4.3.1 Sanofi 26
4.3.2 Novartis 30
4.3.3 GlaxoSmithKline 34
4.3.4 Baxter 37
4.3.5 Nuron Biotech 39
4.3.6 Pfizer 41
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 47
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Vaccine Coverage 50
5.4.2 Vaccine Approval vs. Routine Schedule Inclusion 50
5.4.3 Vaccines Included 51
5.4.4 Key Launch Dates 52
5.4.5 General Pricing Assumptions 53
5.4.6 Individual Vaccine Assumptions 54
5.4.7 Pricing of Pipeline agents 61
5.5 Physicians and Specialists Included in this Study 62
5.6 About the Authors 66
5.6.1 Author(s) 66
5.6.2 Reviewer(s) 66
5.6.3 Epidemiologist(s) 67
5.6.4 Global Head of Healthcare 68
5.7 About GlobalData 69
5.8 Disclaimer 69



List of Tables

Table 1: Global Sales Forecasts ($m) for Meningococcal Vaccines, 2012-2022 14
Table 2: Global Meningococcal Vaccines Market - Drivers and Barriers, 2012-2022 16
Table 3: Key Companies in the Meningococcal Vaccines Market, 2012 23
Table 4: Sanofi’s Meningococcal Vaccines Portfolio Assessment, 2012 28
Table 5: Sanofi SWOT Analysis, 2012 29
Table 6: Novartis’ Meningococcal Vaccines Portfolio Assessment, 2012 32
Table 7: Novartis SWOT Analysis, 2012 33
Table 8: GSK’s Meningococcal Vaccines Portfolio Assessment, 2012 35
Table 9: GSK SWOT Analysis, 2012 36
Table 10: Baxter’s Meningococcal Vaccines Portfolio Assessment, 2012 38
Table 11: Baxter SWOT Analysis, 2012 38
Table 12: Nuron Biotech’s Meningococcal Vaccines Portfolio Assessment, 2012 40
Table 13: Nuron Biotech SWOT Analysis, 2012 40
Table 14: Pfizer’s Meningococcal Vaccines Portfolio Assessment, 2012 42
Table 15: Pfizer SWOT Analysis, 2012 42
Table 16: Key Launch Dates 52
Table 17: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 65



List of Figures

Figure 1: Global Sales for Meningococcal Vaccines by Region, 2012-2022 15
Figure 2: Company Portfolio Gap Analysis in Meningococcal Vaccines, 2012-2022 23



Companies Mentioned

Sanofi
Novartis
GlaxoSmithKline
Baxter
Nuron Biotech
Pfizer

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected ...

Antibiotics: Technologies and Global Markets

Antibiotics: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Identify the major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets. - Learn about developments ...

Antifungal Drugs : Technologies and Global Markets

Antifungal Drugs : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This report aims to determine the current status of the global human antifungal market and assess its growth potential over the five-year period from 2013 through 2018. It covers approved human therapeutics ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.